HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,041-2,052 of 4,505
Drug study icon
CompletedNCT00455715

A Single-Dose study of Sildenafil in Schizophrenia

Official study title

A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia

This study has finished and is no longer accepting participants.

In Boston
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00351936

A Cross-Over study of Aripiprazole

Official study title

A Placebo-Controlled, Cross-Over Trial of Aripiprazole Added to Obese Olanzapine-Treated Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Boston
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
North Suffolk Mental Health Association
Drug study icon
TerminatedNCT00934635

Positron-Emission-Tomography Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone for schizophrenia

Official study title

The "Therapeutic Window" of the "Atypical" Antipsychotic Paliperidone Extended Release (ER)-A Positron Emission Tomography Study With [18F]Fallypride as the Radiotracer

This study ended early.

In Aachen
SchizophreniaMedication studyAges 18–50
Countries
Germany
Sponsor
Janssen-Cilag G.m.b.H
Drug study icon
CompletedNCT02164981

A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia

Official study title

A Randomized Double-Blind, Placebo-Controlled, Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Boston
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT02192723

A study With 6 Antipsychotic Drugs for Schizophrenia

Official study title

Effectiveness of 6 Antipsychotic Drugs in the Treatment of Acute Exacerbations of Chronic Inpatients With Schizophrenia: a Randomized Double-blind Study

This study has finished and is no longer accepting participants.

In Beijing
SchizophreniaMedication studyAges 25–60
Countries
China
Sponsor
Beijing HuiLongGuan Hospital
Drug study icon
CompletedNCT00350467

Extended Release(ER) Paliperidone for schizophrenia

Official study title

A Randomized, 6-week Double-blind, Parallel Study to Evaluate the Efficacy and the Safety of Flexible Doses of Extended Release OROS Paliperidone Compared With Olanzapine in the Treatment of Patients With Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Beijing
SchizophreniaMedication studyAges 18–65
Countries
China
Sponsor
Xian-Janssen Pharmaceutical Ltd.
Drug study icon
CompletedNCT03319953

Effects of TAK-041 on Motivational Anhedonia for schizophrenia

Official study title

A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Subjects With Stable Schizophrenia

This study has finished and is no longer accepting participants.

In London
SchizophreniaMedication studyAges 18–60
Countries
United Kingdom
Sponsor
Neurocrine Biosciences (Biotech company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.